CRGXUnknownMicro-Cap
CARGO Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for CARGO Therapeutics, Inc. (CRGX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are CRGX insiders buying or selling?
CARGO Therapeutics, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since November 2023, Trabud has recorded 9 Form 4 filings for CRGX: 4 buys ($45.0M) and 5 sells ($413.3K).
Source: SEC EDGAR Form 4
Key Statistics (November 2023 – Jul 3, 2025)
Total Form 4 filings
9
SEC EDGAR
Insider filers
5
Insider buys (4)
$45.0M
Insider sells (5)
$413.3K
Insider sentiment
Net buyingNet insider flow of $44.6M in net buying since November 2023.
Recent CRGX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | Anup Radhakrishnan | Title: Interim Chief Executive Officer, Chief Financial Officer and Chief Operating Officer | Sale | 1.6K | $4.18 | $6.8K | SEC ↗ |
| May 16, 2025 | Anup Radhakrishnan | Title: Interim Chief Executive Officer, Chief Financial Officer and Chief Operating Officer | Sale | 27.4K | $3.84 | $105.3K | SEC ↗ |
| Apr 8, 2025 | Anup Radhakrishnan | Title: Interim Chief Executive Officer, Chief Financial Officer and Chief Operating Officer | Sale | 1.6K | $4.00 | $6.5K | SEC ↗ |
| Sep 20, 2024 | Gina Chapman | President & CEO | Sale | 10.1K | $25.07 | $254.2K | SEC ↗ |
| Sep 20, 2024 | Anup Radhakrishnan | Chief Financial Officer | Sale | 1.6K | $25.28 | $40.5K | SEC ↗ |
| Jun 4, 2024 | Srinivas Akkaraju | 10% Owner | Purchase | 294.0K | $17.00 | $5.0M | SEC ↗ |
| Nov 17, 2023 | Srinivas Akkaraju | 10% Owner | Purchase | 666.7K | $15.00 | $10.0M | SEC ↗ |
| Nov 15, 2023 | Third Rock Ventures V, L.P. | 10% Owner | Purchase | 1.3M | $15.00 | $20.0M | SEC ↗ |
| Nov 14, 2023 | Joseph Edelman | Other | Purchase | 666.7K | $15.00 | $10.0M | SEC ↗ |
Showing the 9 most recent of 9 Form 4 filings for CARGO Therapeutics, Inc..
Most active CRGX insiders
- Anup Radhakrishnan4 filings
- Srinivas Akkaraju2 filings
- Gina Chapman1 filing
- Joseph Edelman1 filing
- Third Rock Ventures V, L.P.1 filing
Ask anything about CRGX insider activity
Use Trabud's AI agent to query CARGO Therapeutics, Inc.'s Form 4 history in plain English — "Show me CRGX CEO purchases this year" or compare it against any other ticker.
Open the AI agentCRGX insider trading FAQ
Are CARGO Therapeutics, Inc. insiders buying or selling?
CARGO Therapeutics, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since November 2023, Trabud has recorded 9 Form 4 filings for CRGX: 4 buys ($45.0M) and 5 sells ($413.3K). Over the full record that is net buying of $44.6M.
How many insiders trade CRGX stock?
5 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for CARGO Therapeutics, Inc.. The most recent filing was accepted on Jul 3, 2025.
Where does Trabud get CRGX insider trading data?
All CRGX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.